SCHEMBL20524312

SCHEMBL20524312

Cc1n[nH]cc1/C=C\C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFKB1 P19838 2/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA4 P22748 1/20 0.39
MAP3K7 O43318 1/20 0.39
TAB1 Q15750 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
ALDH1A1 P00352 3/20 0.39
GAA P10253 3/20 0.39
NPC1 O15118 2/20 0.39
HTT P42858 1/20 0.38
APEX1 P27695 1/20 0.38
TDO2 P48775 1/20 0.37
KDM4E B2RXH2 3/20 0.37
EIF2AK2 P19525 1/20 0.37
CSNK2A2 P19784 1/20 0.37
CSNK2B P67870 1/20 0.37
CSNK2A1 P68400 1/20 0.37
THRB P10828 1/20 0.37
ATM Q13315 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20524343 1.00 NFKB1 (0.39) NFKB1CA1CA2CA4MAP3K7
SCHEMBL7489005 1.00 NFKB1 (0.39) NFKB1CA1CA2CA4MAP3K7
SCHEMBL7486894 0.82 ALDH1A1 (0.45) CA1CA2MAP3K7TAB1SMN1; SMN2
SCHEMBL11557165 0.78 CA1 (0.39) NFKB1CA1CA2CA4MAP3K7
SCHEMBL11557166 0.78 CA1 (0.39) NFKB1CA1CA2CA4MAP3K7
SCHEMBL17843957 0.77 MAP3K7 (0.39) NFKB1CA1CA2CA4MAP3K7
SCHEMBL7470388 0.77 MAP3K7 (0.39) NFKB1CA1CA2CA4MAP3K7
SCHEMBL20525190 0.75 CDK4 (0.36) ALDH1A1
SCHEMBL8914275 0.74 TNFRSF1A (0.38) NFKB1CA1CA2CA4MAP3K7
SCHEMBL8914271 0.74 TNFRSF1A (0.38) NFKB1CA1CA2CA4MAP3K7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3860995-A1 ISOQUINOLINE COMPOUNDS FOR THE TREATMENT OF CANCER F. Hoffmann-La Roche AG (CH) 2021-08-11 EP disclosed
WO-2020072627-A1 ISOQUINOLINE COMPOUNDS FOR THE TREATMENT OF CANCER GENENTECH, INC. (US) 2020-04-09 WO disclosed
EP-3601284-A1 NAPHTHYRIDINES AS INHIBITORS OF HPK1 H. Hoffnabb-La Roche Ag (CH) 2020-02-05 EP disclosed
EP-3601259-A1 ISOQUINOLINES AS INHIBITORS OF HPK1 H. Hoffnabb-La Roche Ag (CH) 2020-02-05 EP disclosed
WO-2018183964-A1 ISOQUINOLINES AS INHIBITORS OF HPK1 GENENTECH, INC. (US) 2018-10-04 WO disclosed
WO-2018183956-A1 NAPHTHYRIDINES AS INHIBITORS OF HPK1 GENENTECH, INC. (US) 2018-10-04 WO disclosed